Cargando…
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience
The aim of this study is to access the feasibility, toxicity profile, and tumour outcome of an organ preservation curative approach in non-metastatic muscle-invasive bladder cancer. A retrospective analysis was conducted on patients affected by M0 bladder cancer, who refused cystectomy and were trea...
Autores principales: | Gerardi, Marianna A., Jereczek-Fossa, Barbara A., Zerini, Dario, Surgo, Alessia, Dicuonzo, Samantha, Spoto, Ruggero, Fodor, Cristiana, Verri, Elena, Rocca, Maria Cossu, Nolè, Franco, Muto, Matteo, Ferro, Matteo, Musi, Gennaro, Bottero, Danilo, Matei, Deliu V., De Cobelli, Ottavio, Orecchia, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970626/ https://www.ncbi.nlm.nih.gov/pubmed/27563352 http://dx.doi.org/10.3332/ecancer.2016.657 |
Ejemplares similares
-
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome
por: Riva, Giulia, et al.
Publicado: (2017) -
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches
por: Marvaso, Giulia, et al.
Publicado: (2021) -
Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case report
por: Vavassori, Andrea, et al.
Publicado: (2020) -
Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics
por: Xu, Xianglai, et al.
Publicado: (2021) -
The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M
por: Sun, Jian-Xuan, et al.
Publicado: (2023)